Education
About Us
Working with TipRanks
Follow Us
PMGC Holdings (ELAB)
NASDAQ:ELAB
ELAB Stock Chart & Stats
$1.55
-$0.19(-8.12%)
At close: 4:00 PM EST
$1.55
-$0.19(-8.12%)
Day’s Range― - ―
52-Week Range$1.01 - $122.01
Previous CloseN/A
Volume180.10K
Average Volume (3M)89.87K
Market Cap
$3.28M
Enterprise Value-$2.20M
Total Cash (Recent Filing)$8.50M
Total Debt (Recent Filing)$5.39M
Price to Earnings (P/E)―
Beta1.15
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding3,248,764
10 Day Avg. Volume35,159
30 Day Avg. Volume89,868
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.77
Price to Sales (P/S)2.07
P/FCF Ratio-0.93
Enterprise Value/Market Cap-0.67
Enterprise Value/Revenue1.50
Enterprise Value/Gross Profit1.28
Enterprise Value/Ebitda0.52
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strategic AcquisitionThe acquisition of Indarg Engineering enhances PMGC's manufacturing capabilities and market position in aerospace and defense, supporting long-term growth.
AI-Driven Drug DevelopmentAdvancing AI-driven drug development positions PMGC to capitalize on innovative therapies for obesity, potentially strengthening its market presence in biotechnology.
Certification AchievementAS9100 certification enhances AGA's credibility and ability to secure complex aerospace and defense contracts, supporting sustained business growth.
Bears Say
Ongoing Cash BurnPersistent negative cash flow indicates the company is not self-funding, posing risks to long-term financial stability and operational sustainability.
Revenue VolatilitySignificant revenue volatility undermines predictability and reliability of income streams, challenging the company's ability to sustain growth.
Weak ProfitabilityContinued losses and negative profitability highlight challenges in achieving sustainable operations and financial health, impacting long-term viability.
PMGC Holdings News
ELAB FAQ
What was PMGC Holdings’s price range in the past 12 months?
PMGC Holdings lowest stock price was $1.01 and its highest was $122.01 in the past 12 months.
What is PMGC Holdings’s market cap?
PMGC Holdings’s market cap is $3.28M.
When is PMGC Holdings’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were PMGC Holdings’s earnings last quarter?
Currently, no data Available
Is PMGC Holdings overvalued?
According to Wall Street analysts PMGC Holdings’s price is currently Overvalued.
Does PMGC Holdings pay dividends?
PMGC Holdings does not currently pay dividends.
What is PMGC Holdings’s EPS estimate?
PMGC Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PMGC Holdings have?
PMGC Holdings has 3,248,764 shares outstanding.
What happened to PMGC Holdings’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of PMGC Holdings?
Currently, no hedge funds are holding shares in ELAB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
PMGC Holdings
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operates investment firms. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.
Technical Analysis
Biodexa Pharmaceuticals
―
―
Indaptus Therapeutics
―
InMed Pharmaceuticals
―
CNS Pharmaceuticals
―